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Commentary
Going beyond the code
Protein engineering is all about obtaining proteins not immediately
available in Nature. Recombinant methods are, rightly, the most
often used for that purpose and normally should be considered
as the first option. Recombinant methods (when all goes well)
are rapid and the simplicity with which they can be transferred
to a new protein system is unrivalled by any other approach. They
are, in short, conveniently adapted to the needs of the 'kit
generation' of biological scientists and are all the better for that.
On the other hand, methods calling for direct intervention at
the protein level have more to offer than mere historical interest:
when they work, they work well, and in the most favourable
cases with a convenience that it is hard to imagine being bettered
in any other way, recombinant approaches included. It is not a
coincidence, for example, that much of the human insulin used
by the World's diabetics is obtained not by recombinant means,
but semisynthetically, by chemical transformation of porcine
insulin. Moreover, the advantages of the protein—chemical
approach are not limited to being appropriate for bulk production.
To remain with insulin, an earlier Commentary (Offord, 1987)
discussed the elegant combination of recombinant and semi-
synthetic methods used at the laboratory scale by Markussen's
group (Markussen et al., 1989a,b) to produce a whole range of
new insulin molecules. Finally, when mentioning non-
recombinant approaches, we should not forget total synthesis as
a promising means of producing analogues of small and even
medium-sized proteins (e.g. Woo et al., 1989).
Chemical methods are particularly worthy of consideration
when substitutions are required that involve either non-coded
residues or non-peptide links in the main chain, or where some
site-specific post-translational modification, e.g. C-terminal
amidation, defeats the expression systems normally used. This
general topic, has been reviewed by Offord (1990), and by Rose
et al. (1991a). However, it was long predicted (e.g. Offord,
1980) that the recombinant approach would also be able to
contribute in this area and, as is well known, this has indeed
happened in the last couple of years. Some recent papers (Bain
etal., 1991; Mendel et al., 1991, Abrahamse'n et al., 1991: Rose
et al., 1991b) permit us to evaluate the current state of the field,
both as regards recombinant and semisynthetic methods.
First, two papers on the recombinant approach, one (that of
Bain et al.) primarily methodological and one (that of Mendel
et al.) directed to exploiting the methodology to study a protein
structure —function relationship.
The brief review of the origins of the recombinant approach
to working outside the code, given in the introduction to the paper
by Bain etal., although written entirely from a molecular
geneticist's, rather than a protein chemist's standpoint, is well
worth reading in itself. But the main interest in the paper is the
extension of the authors' previous methodological contribution
in this area. Briefly, Bain et al. prepared semisynthetic nonsense-
suppressor tRNA, chemically acylated with L-3-[l25I]iodotyrosine,
jV-methyl-L-phenylalanine, D-phenylalanine or L-phenyllactic
acid. The parent tRNA sequence was tRNAGly3, but having,
among other modifications, its anticodon replaced by the
appropriate suppressor triplet. Bain et al. used principally the
amber suppressor but also did some work with tRNAs having
the ochre and opal anticodon. The object, of course, was to see
if these chemically acylated tRNAs would suppress the effect of
the corresponding 'stop' codon, i.e. instead of bringing peptide
chain elongation to an end, insert their aminoacyl residue in the
chain, and permit synthesis to continue until one of the other
possible 'stop' signals was encountered. To study this possibility
in a completely controlled way, the authors constructed an mRNA
which, in a cell-free system, would give an octapeptide if the
target 'stop' codon were allowed its normal function, and a
hexadecapeptide (with the chemically introduced residue in the
ninth position) if the 'stop' signal was suppressed.
Careful study of the behaviour of all these components in
reticulocyte lysates gave firm evidence that things had worked
as planned. Using the iodotyrosine derivative with the amber
suppressor, as much as 65 % of the translated sequence appeared
to be the wanted hexadecapeptide. The yV-methyl amino acid was
incorporated with about the same efficiency, whereas the r>amino
acid was not incorporated at all. The incorporation efficiency
of phenyllactate (thus, with an ester bond between residues 9 and
10 of the peptide chain) was 46%, a truly remarkable result.
The other leading group in this field (Mendel et al., 1991) have
also further developed their early work. These authors have used
their version of the same general approach as that just described
to construct a mutant of T4 lysozyme in which Asp20 should
be specifically esterified by o-nitrobenzoic acid. The reason for
doing so is that Asp20 forms part of the catalytic site, in that
it is thought to stabilize a carbocation intermediate by electrostatic
interaction. Even leaving the question of its bulk aside, the
nitrobenzoic ester would clearly not be able to do this, and the
mutant should be inactive. But. since o-nitrobenzoic esters are
photolabile, irradiation of the mutant enzyme should restore
activity. A suppressor tRNA was prepared, chemically acylated
with /3(o-nitrobenzoyl)-Asp, and protein biosynthesis carried out
in a cell-free system, directed by a plasmid encoding either the
enzyme with the appropriate changes to the codon corresponding
to position 20 or the wild-type sequence. Everything worked as
hoped for: an inactive mutant enzyme was produced, identified
with suitable controls by radioautography of gel electrophoreto-
grams, at several tens of/ig/ml, and shown to be photoactivatable.
This finding constitutes useful support to the original hypothesis
concerning the enzyme's mechanism, and although the evidence
does not yet meet the standard required in protein-chemical
exercises of this type (direct analytical demonstration that the
substitution is the one intended, and that it really is at the intended
site, and only there), there is good inferential evidence that all
is well.
In both of these papers the quantity of product is small, and
in Bain et al. (1991) identification and characterization is quite
indirect, relying on the detection of relatively modest quantities
of radioactivity. In Mendel et al. (1991), detection depends on
radioautography and enzyme assay. That more material is not
available is due to the current need to work in cell-free rather
than in vivo systems, and perhaps also to the great complexity
(greater than in most modern protein semisyntheses) of the
chemical work required to make the acylated suppressor tRNAs.
Neither of these two papers seeks to conceal these difficulties,
and in the words of Bain et al. "we are currently expanding our
research to address these two issues'. There is quite a way to
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go yet, but given the recent history of molecular genetics, one
can hardly be other than optimistic.
Meanwhile protein-based methodology continues to make
progress. Most current work is based on the stratagem, originally
made popular in the field by the work of Laskowski (1978), that
proteases can be made to work in reverse, (i.e. as ligases) even
with large protein substrates, while retaining much of the
specificity of action. Thus, to take but one of the many enzymes
now used for this purpose, trypsin normally cuts on the
C-terminal side of lysyl and arginyl residues, but can be made
to ligate peptides with C-terminal Lys or Arg to a wide variety
of other compounds, including amino-acid derivatives and
peptides. None of the complicated side-chain protection schemes
of conventional peptide synthesis are needed, since the preference
of proteins for the substituents of the a-carbon will normally mean
that there is no danger of reactions involving side chains.
Space does not permit us to develop the theory of this method
here [see Laskowski (1978) and Kullmann (1987) for a complete
discussion]. It is perhaps sufficient to say that there is a kinetic
approach to the problem and a thenmodynamic one. The kinetic
approach exploits the fact that, under appropriate conditions,
ligation products are transiently formed on the way to hydrolysis,
and can be trapped. The thermodynamic approach relies both
on mass action to push the reaction in the direction of synthesis,
and on changes to the equilibrium constant itself, brought about
by altering the dielectric constant of the medium by the addition
of a water-miscible, uncharged organic solvent (e.g. glycerol,
various diols, dimethylsuphoxide, etc). Since the standard free
energy of reaction does not greatly favour hydrolysis, if at all,
these quite simple manoeuvres often permit rapid and clean
ligations.
Of two recent papers, one (Abrahmse'n et al., 1991) is,
formally speaking, related to the kinetic approach, while the other
(Rose et al., 1991b) deals with the thermodynamic approach.
Abrahmse'n et al., recognizing the potential of recombinant
techniques to tailor proteases to function as better ligases, have
engineered an analogue of subtilisin which ligates efficiently in
water. They present to the enzyme the substrate that donates its
a-COOH to the new peptide bond not as a free protein or peptide,
but as the a-ester. In the mutant enzyme, to improve esterolysis
while reducing amidase activity, the catalytic serine has been
replaced by cysteine, something that, as Abrahmse'n et al. point
out, has been done previously by other workers. However, in
the present case, crowding caused by the greater size of the -SH
group relative to the OH-group was alleviated by mutating a
second site, one helix turn away from the catalytic residue (proline
in the wild type, alanine in the mutant). As hoped, the mutant
proved to be a quite efficient esterase but a very inefficient
amidase. Thus, ester substrates readily form the customary acyl-
enzyme intermediates, whereas there would be much less
tendency to cleave other peptide bonds. As in most cases of
ligation by proteases, whether kinetic or thermodynamic, the new
peptide bond is formed by attack on the acyl-enzyme intermediate,
not by water (which is what is required for hydrolysis) but by
the amino group of the second component destined to complete
the peptide bond. In the present case, not only did the mutant
enzyme perform to specification in trial ligations, but the authors
even carried out further mutations at the specificity site to give
three new variants, each having different preferences in the P,
site.
It would have been interesting to see what degree of ligation
would have been obtained, and under what conditions, using a
non-esterified substrate. The principle of microscopic reversibility
shows that such substrates, too, must give the acyl intermediate.
Of course, while in most thermodynamically driven ligations the
free a-COOH group actually renders the process more rapid and
efficient than one involving the prior removal or a substituent
of the a-COOH, such a result would scarcely be expected in the
present case.
This is a very detailed paper, including the 1.5 A X-ray structure
of the principal mutant, and deserves to be read in detail.
It would not be fair to give too extensive a commentary on
a paper coming from this Laboratory, but the reader might like
to glance at Rose et al. (1991b) to see some of the things of which
the thermodynamic approach is now capable. This work, directed
at finding ways of using ligation for the site-specific modification
of antibodies and other target-directed proteins, shows, in a simple
protein system, how readily non-coded functional groups
(aldehydes and hydrazides) can be introduced at the C-terminus
of a peptide chain. Chosen for their potential value in site-specific
conjugation to other molecules, these groups have a good
reactivity in mild aqueous conditions, while nonetheless having
a profile of chemical response quite unlike that of any amino acid
side chain.
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